Global Cell Cryopreservation Market Report 2024: Market Size, CAGR, Lucrative Segments And Top Regions

Cell cryopreservation is the process of preserving cells by cooling them to sub-zero temperatures, typically in liquid nitrogen at -196°C. This method halts all biological activity and metabolism, allowing cells to be stored for extended periods without degradation. Cryoprotective agents are used to prevent ice crystal formation, which can damage cell structures during freezing and thawing.

Sizing and Forecast
The cell cryopreservation market size has grown exponentially in recent years. It will grow from $10.21 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 23.8%. The  growth in the historic period can be attributed to increasing demand for cell-based therapies, rise in biomedical research, growing need for organ transplantation, rise in R&D activities for cell based therapies and increasing use of cryopreserved cell.

The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $29.9 billion in 2028 at a compound annual growth rate (CAGR) of 24%.  The growth in the forecast period can be attributed to rising demand for in vitro fertilization (IVF) procedures, advancement in organ transplantation procedures, expansion of biobanking activities, rising incidence of chronic diseases and positive government initiatives and funding. Major trends in the forecast period include advancements in cryopreservation techniques,  advancements in MRNA vaccine storage and transportation, advancements in cryoprotectants and freezing techniques, growing trend towards personalized medicine and advancements in stem cell research.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/cell-cryopreservation-global-market-report

Segmentation & Regional Insights
The cell cryopreservation market covered in this report is segmented –
1) By Product: Cell Freezing Media, Equipment, Consumables
2) By Application:  Hepatocytes, Stem Cells, Oocytes And Embryotic cells, Sperm Cells, Other Applications
3) By End-Use Channel: Biopharmaceutical And Pharmaceutical Companies, Research Institutes, Biobanks, In Vitro Fertilization (IVF) Clinics, Other End-Use Channels

North America was the largest region in the cell cryopreservation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15755&type=smp

Major Driver Impacting Market Growth
The increasing number of organ transplantation procedures is expected to propel the growth of the cell cryopreservation market going forward. Organ transplantation is a medical procedure where a damaged or failing organ is replaced with a healthy organ from a donor. Organ transplant procedures are increasing due to organ failure caused by hereditary abnormalities, infections, traumas, and chronic diseases. Cell cryopreservation in organ transplantation involves freezing and storing cells from organs to preserve their viability for future use, enhancing graft success, and reducing immune rejection. For instance, in January 2024, according to the Health Resources and Services Administration, a US-based federal agency, in 2023, there were 46,632 organ transplants performed from both living and deceased donors, marking an 8.7% increase from 2022 and a 12.7% increase from 2021, which was the first year with over 40,000 organ transplants. Therefore, increasing organ transplantation procedures are driving the growth of the cell cryopreservation market.

Key Industry Players
Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., BioLife Solutions Inc, Nkarta Inc., Tn-Sanso Corporation, Coya Therapeutics, FUJIFILM Irvine Scientific, Artiva Biotherapeutics, Acorn Biolabs Inc., ThermoGenesis Holdings Inc., Evia Bio Inc., Wideblue Limited, Akron Biotech, Captivate Bio LLC, Pluristyx Inc., CryoCrate LLC, PanTHERA CryoSolutions, ParaTechs Corporation, Plus Therapeutics, X-Therma Inc., Protein Technologies Limited

The cell cryopreservation market report table of contents includes:
1. Executive Summary
2. Cell Cryopreservation Market Characteristics
3. Cell Cryopreservation Market Trends And Strategies
4. Cell Cryopreservation Market - Macro Economic Scenario
5. Global Cell Cryopreservation Market Size and Growth
……………….
32. Global Cell Cryopreservation Market Competitive Benchmarking
33. Global Cell Cryopreservation Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Cell Cryopreservation Market
35. Cell Cryopreservation Market Future Outlook and Potential Analysis
36. Appendix